Elderly patients with heart failure tolerated the nebivolol (Nebilet, Forest) well. In fact, 67% of 1,031 patients assigned to receive the beta blocker reached the target dose of 10 mg/day, 80% reached a maintenance dose of at least 5 mg, and approximately 70% of patients remained on the same maintenance dose until the end of the 16-week trial.

Read the rest of this entry »